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1. Introduction 
The relentless progress that is being made in tomographic imaging modalities is inexorably 
expanding the application of positron emission tomography (PET) in the clinical field. Some 
of the most noteworthy advances involve innovations in quantitative techniques for hybrid 
imaging modalities such as PET/Computed Tomography (CT) and PET/Magnetic 
Resonance Imaging (MRI), which have greatly improved the ability to segment and analyze 
functional images produced with radiotracers such as (18F) Fluorodeoxyglucose (FDG). With 
continued technological progress, quantitative approaches can supplant the more subjective 
qualitative and semi-quantitative techniques that currently dominate the clinical use of PET. 
Although it does not meet the rigorous standards for objectivity in medical research, the 
qualitative method of visual assessment continues to be very prevalent in the clinical field. 
The benefits of this technique’s simplicity are offset by its immense subjectivity and the 
consequent lack of reproducibility and pervasiveness of inter-reader variability. These 
limitations are mitigated in the somewhat more consistent semi-quantitative technique of 
standardized uptake value (SUV), but concerns about reproducibility still linger. The 
manual delineation of the regions of interest (ROIs) within an image maintains a degree of 
subjectivity that hinders the reproducibility of the analysis. Therefore, while these 
methodologies may be less demanding, they open the door to the possibility of variability. 
Using structural and functional imaging, namely PET/CT and PET/MRI, and combining 
structural information with functional data by various quantitative techniques provide a far 
more objective method of image analysis, but also carry their own set of inherent difficulties. 
This method of quantification is far more technically demanding and requires complex 
mathematical computations1,2.  
Despite its limitations, it appears likely that quantitative analysis of hybrid imaging will 
become the method of choice in the future. Recent developments in tomographic imaging 
have improved the ability of PET to accurately assess global function in addition to the more 
conventional ROI analysis. Global assessment, which combines data on the activity of a 
lesion measured by PET and its segmented volume defined by CT, has wide-reaching 
applications in a diverse range of medical fields. The viability of this alternative method 
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depends on the accuracy of segmentation and quantification, as well as the alleviation of 
some of the inherent obstacles of hybrid imaging. 
2. Classifications of PET data analysis 
The techniques employed for the analysis of functional images can be subdivided into three 
categories: qualitative, semi-quantitative, and quantitative. The first of these three is by far 
the most subjective, and entails the visual interpretation of data by human observers. The 
second utilizes indices such as SUV and lesion-to-background ratio to measure activity in 
assigned regions of interest. Lastly, the third employs more complex mathematical and 
technical processes, such as non-linear regression and Patlak-Gjedde graphical analysis. 
Despite the superior reproducibility and objectivity it provides, this final technique is 
arguably rendered impractical for clinical use by its technical rigors. On the other hand, the 
other two techniques are far more susceptible to both inter-reader and intra-reader 
variability, but are widely employed due to their simplicity.  
3. Models for quantifying absolute glucose metabolic rate 
The metabolic rate of glucose is estimated with the aid of FDG, an analog of glucose that is 
currently the most widely used PET radiotracer3,4,5. The metabolism of FDG is in turn 
measured through kinetic modeling of the data6. This process reveals a series of rate 
constants that shed light not only on the absolute metabolic rate, but also the steps within 
glucose metabolism. 
 
Fig. 1. The three-compartment model involves the transport of FDG from the plasma to the 
cell, as well as the phosphorylation and dephosphorylation of FDG within the cell. Simpler 
models ignore the dephosphorylation of FDG, thereby eliminating the k4 rate constant. 
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When dealing with FDG, the tracer kinetic model comprises three compartments that 
encompass the processes of transportation and phosphorylation. More specifically, these 
compartments demarcate the FDG in the blood plasma, the FDG in the cell, and the FDG-6-
phosphate in the cell (Fig. 1). The first compartment (C1) is assumed to be open, with free 
exchange with other tissues in the body. It is for this reason that the input function of this 
compartment (i.e., FDG levels in the plasma) cannot be calculated and must be measured by 
arterial sampling. The second compartment (C2) refers to FDG that is in the tissue and not in 
the vasculature. These pools of FDG in the cell are available for phosphorylation by 
hexokinase. Once FDG is in its phosphorylated form, it occupies the third compartment 
(C3).  
If a kinetic model accounts for the dephosphorylation of FDG-6-phosphate by glucose-6-
phosphatase in addition to transportation and phosphorylation, it is termed “reversible.”7 
However, this three-compartment model is far from the only one in use; more simplified 
“irreversible” models often ignore the dephosphorylation of FDG on the assumption that 
the incorporation of fewer parameters will lower variance.1 These methods include non-
linear regression analysis, which estimates a single rate constant Ki in the place of k1, k2, and 
k3, and Patlak-Gjedde graphical analysis, which calculates activity as a function of the 
concentration, distribution volume, and net rate of influx of FDG.8  
By applying this simplified irreversible model to dynamic PET data, non-linear regression 
analysis can estimate the net rate of FDG influx. The advantages of this method of 
quantification include its lack of dependence on the length of time over which uptake occurs 
and its ability to provide insight into the rate constants behind glucose metabolism. But on 
the other hand, the technical complexity of the method makes it demanding and time-
consuming, with the required arterial sampling only exacerbating these issues.  
In comparison to non-linear regression, the method of Patlak-Gjedde graphical analysis is 
more robust due to a simpler scanning protocol that is less susceptible to noise. This 
technique, which also has the ability to produce parametric images, is modeled by the 
following equation: 
      Ͳ
t
p i pc t c t K c d        
where  
c(t) = activity in the tissue as measured by the PET scanner at time t, 
cp(t) = concentration of FDG in the plasma, 
λ = distribution volume of FDG, 
Ki = net rate of FDG influx into the tissue, and 
 is a dummy integration variable 
Unlike non-linear regression, Patlak-Gjedde graphical analysis cannot calculate individual 
rate constants for the metabolism of glucose. But similar to non-linear regression, it requires 
dynamic scanning, which carries with it a host of limitations.  
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Dynamic scanning, which is crucial to both non-linear regression and Patlak-Gjedde 
graphical analysis, entails an extended sequence of acquisitions that are subsequently 
reconstructed. The high availability of dynamic data, which is comparatively less dependent 
on imaging time, works to the advantage of these quantitative techniques. On the other 
hand, the rigors of the procedure make it technically demanding and time-consuming. 
Moreover, since only one bed position can be assumed per scan, each lesion may have to be 
acquired separately. The need to quantify FDG concentration in the plasma also necessitates 
arterial blood sampling at several points during the scan.  
The arterial sampling performed during dynamic scans allows for the extrapolation of time-
vs.-activity curves, which can yield rate constants through non-linear least squares 
approximation. This approach to quantifying FDG activity is certainly more objective than 
more popular alternatives such as SUV and visual assessment, but is far from immune to 
error. First and foremost, the assumption that FDG-6-phosphate is not dephosphorylated 
once it is inside the cell is overly simplistic and can lead to inaccurate estimates. Variance 
due to imaging noise and partial-volume effects further limit these methods of 
quantification. 
In addition to non-linear regression and Patlak-Gjedde graphical analysis, there exist other, 
more simplified kinetic methods for quantifying the rate of glucose metabolism. This is done 
using only a single static scan, albeit with somewhat lower accuracy. An autoradiographic 
method developed by Sokoloff et al. is one such single-scan method, but is still limited by 
the need of arterial sampling to determine FDG concentration9,10. A similar technique 
devised by Hunter et al. is able to quantify metabolic rates with the aid of limited venous 
blood sampling11.  
4. Quantification of activity through SUV 
Standardized uptake value (SUV)—also known as differential absorption ratio (DAR), 
differential uptake ratio (DUR), and standardized uptake ratio (SUR)—is currently the most 
common semi-quantitative index employed in the clinical field. It has the ability to measure 
FDG metabolism through tracer concentration in the tissue. It is calculated according to the 
following formula: 
 ͳ8ȋ / Ȍ ͳȋ Ȍ ȋ ȌMeanROI concentration MBq mlSUV Injecteddose MBq Bodyweight g decay factor of F    
The advantages of SUV lie in its ease of use; when compared to the aforementioned kinetic 
models, SUV is far less technically demanding and computationally complex. The fact that 
its values are automatically estimated by software makes the SUV method highly expedient 
for clinical use. The lack of dependency on arterial sampling and the comparatively short 
scanning time also work in its favor. In spite of these shortcuts, kinetic modeling reveals a 
strong correlation between SUV and glucose metabolic rate. However, that is not to say that 
SUV measurements are not just as—if not more—prone to error than kinetic modeling 
(Table 1). 
Currently, PET scanners are most often normalized to the body weight of the patient. This 
causes the systematic overestimation of SUV in obese patients, since adipose tissue 
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demonstrates comparatively low FDG uptake because of its dampened metabolic activity. 
Studies that employed the parameters of lean body mass and body surface area instead of 
body weight were found to be more accurate12,13,14.  
a. Patient-Related Factors 
Factor Effects Corrective measures 
Body size and habitus 
(3.3) 
SUV in obese patients 
overestimates FDG uptake relative 
to normal patients 
Use of lean body mass 
(SUVLBM) or body surface 
area (SUVBSA)  
Serum glucose levels 
(3.4) 
Reduced FDG uptake in target 
tissues with increasing blood 
glucose levels 
Control of blood glucose 
before administering FDG 
and applying correction 
factor for glucose level 
Organ and lesion motion Reduction of SUV Respiratory gating or 4D 
reconstruction 
b. Technical Factors 
Factor Effects Corrective measures 
Duration of uptake 
period (3.5) 
Increase in SUV with increasing 
time in malignant lesions  
Standardization of time of 
image acquisition  
Attenuation correction 
and reconstruction 
methods (spatial filter 
kernel, image resolution, 
number of iterations) 
Underestimation of SUV with 
highly smoothed reconstruction 
Standardize acquisition 
and reconstruction 
algorithms 
Partial-volume effects 
(4.1, 4.2) 
Underestimation of SUV in lesions 
with diameters smaller than 2-3 × 
spatial resolution  
Adopt an optimal partial 
volume correction factor 
Size of the ROI and non- 
uniformity of tracer 
distribution in the lesion 
Low SUVmean for large ROIs and 
high random errors in smaller 
ROIs 
Standard size ROIs placed 
reproducibly in the same 
location, SUVmax preferable 
to SUVmean. 
Organ and lesion motion Mismatch between EM and CT 
data 
Respiratory gating or 4D 
reconstruction 
Table 1. Factors influencing standardized uptake value (SUV) determination for FDG at 
intended regions of interest, their undesirable effects, and associated required corrective 
measures. (Based on Basu et al. [95] with permission from Elsevier Inc.). 
5. Effect of respiratory motion on SUV 
The accuracy of quantification through PET/CT imaging is affected by several factors. 
Historically, one of the most problematic factors—especially in the scanning of thoracic lesions 
or non-small cell cancers—has been respiratory motion, which impacts diagnostic and staging 
accuracy. Misregistration due to respiratory motion in the thorax and abdomen between data 
acquired through PET and CT was reported soon after commercial introduction of PET/CT 
and has been one of the most challenging research topics in the field.  
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Fast gantry rotation of less than one second per revolution and sizeable detector coverage of 
over 2 cm enable CT systems to scan over 100 cm in the cranial-caudal direction in 20 
seconds. By comparison, PET typically requires 2 to 5 minutes to scan 15 cm. The temporal 
resolutions of CT and PET are also disparate: less than 1 second for CT and about one 
respiratory cycle for PET. This discrepancy in temporal resolution may lead to a 
misalignment of the tumor position between the CT and PET data, and may compromise the 
quantification process. 
These issues with misregistration due to motion can be remedied by respiratory gating. 4D-
PET can also be performed on this PET/CT for RT, but its application has been limited due 
to the total acquisition time of approximately 40 minutes. Most patients cannot hold their 
arms over their heads for such a long period of time, and the inevitable motion that results 
compromises the PET data. Moreover, the splitting of coincident events into multiple bins or 
phases and the low spatial resolution of 5 to 10 mm further hinder the applicability of 4D-
PET. When combined with respiratory gating, this technique of 4D-PET yields higher SUVs 
and more consistent tumor volumes between PET and CT.  
6. Factors affecting SUV measurements 
The SUVs of malignant lesion are heavily dependent on glycemic status. Hyperinsulinemia 
causes enhanced glycolysis in adipose tissue and muscles, leading to comparatively low 
SUVs elsewhere. For this reason, the glucose level of patients undergoing PET is normally 
capped at 150 to 200 mg/dl. Studies have shown the elevated blood glucose levels (up to 250 
mg/dl) do not affect SUV in inflammatory or benign lesions.  
Most centers measure SUV at a single time point by assigning ROIs. Variation in the time 
interval between tracer injection and image acquisition, which have a significant effect on 
SUV, is unavoidable to some extent. The confounding effect can be minimized by 
standardizing protocols outlining the time and direction of the scan. The SUV of tumors 
continues to rise for several hours after injection, whereas that of the surrounding non-
malignant tissue can actually fall. As a result, delayed PET scans often demonstrate better 
contrast than early PET scans because of an increased lesion-to-background ratio.  
The overlap between inflammatory and malignant lesions precludes SUV from being able to 
distinguish between them. Dual-time point imaging has been used instead to assess 
malignancies in the head, neck, lungs, breast, cervix, gallbladder, and CNS. The lack of 
glucose-6-phosphatase in the tumor cells relative to normal cells slows the dephosphorylation 
of FDG. This leads to increased contrast between tumor and normal cells over time. This 
also provides a means of differentiating between benign and malignant lesions. 
In many studies of various malignancies, dual-time point imaging improved the sensitivity 
and specificity of PET. The higher specificity is due to the increasing difference in FDG 
uptake over time between malignant and benign lesions. On the other hand, the higher 
sensitivity is due to increased lesion-to-background ratio that results from increased uptake 
in malignancies and the clearance of FDG in other tissues. 
7. Future Implications for SUV 
It has been suggested that SUV is not optimal for classifying tumors. Dual-time point 
imaging and delayed PET imaging may be embraced as a more accurate method in the 
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future. As structural and functional imaging become increasingly fused, it is likely that 
PET/CTs and PET/MRIs will be integral in the assessment of pathophysiological processes.  
8. Correcting for Partial-Volume Effects 
The partial-volume effect (PVE) affects objects that are less than 2 to 3 times the spatial 
resolution of the PET scanner. PVE causes the systematic underestimation of SUVs yielded 
from PET data. Physiological and patient motion also cause the degradation of spatial 
resolution and exacerbate PVE. These difficulties can be compensated for with 4D 
respiratory gated PET/CT. Studies have shown that using anatomic imaging (namely CT) to 
measure the true size of lesions also causes substantial increases in the accuracy of PET data. 
The best resolution that can be achieved by modern clinical whole-body scanners is 4 mm. 
In the field, spatial resolution is normally worse by a significant margin. Structures that are 
less than 2 to 3 times the spatial resolution of the system, as measured by the full-width at 
half-maximum, are subject to PVE. Contrast between a lesion and the background decreases 
the smaller the region is. There are three broadly-defined approaches to minimizing PVE: 
1. Correcting for the loss of resolution after reconstruction; 
2. Incorporating PVE modeling into the reconstruction process; 
3. Using the size of a lesion as determined by anatomic imaging to correct for PVE. 
Correction of PVE was broached as early as the 1980s when CT and PET were used to 
examine patients with AD and other CNS disorders that cause cerebral atrophy. High 
resolution MR imaging has since led to accurate segmentation and measurement in the gray 
matter, white matter, and cerebrospinal fluid (CSF).  
9. Factors affecting recovery coefficients 
The recovery coefficient (RC) is the ratio of observed activity to true activity in PET. It is 
affected by lesion-to-background ratio, matrix size, etc. RC is usually measured in a static 
condition, but is subsequently applied in the field to scans with physiological and patient 
motion. A study carried out by Hickeson et al. reported an increase from 58% to 89% in the 
accuracy of metabolic activity measurements in lung nodues smaller than 2 cm when 
partial-volume effects were corrected for and a threshold SUV of 2.5 was used to 
differentiate between malignant and benign lesions15. 
10. Assessing global metabolic activity 
Global metabolic activity is calculated by multiplying partial-volume corrected SUV and the 
volume of the organ of interest, as determined by CT or MRI. The ability to segment images 
into organs and even subcomponents of organs will no doubt have enormous value in the 
field of oncology. The therapeutic efficacy of treatment on multiple malignancies can be 
better measured in this manner.  
The assessment of disease through global metabolic activity is particularly useful in 
neuropsychiatric disorders, where the measurement of glucose metabolism in the entire 
brain can be a more reliable indicator of disease than that of a single region of interest. 
Atrophy-corrected whole brain metabolism shows a high degree of sensitivity to and 
correlates well with cognitive function, as measured by mini-mental status examinations16.  
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Global metabolic activity was first measured in studies of AD by Alavi et al.1. It was 
calculated by multiplying segmented brain volumes—as determined by MR—by the mean 
metabolic rate for glucose to yield metabolic volumetric product (MVP). Volume has to be 
measured accurately by algorithms on computers, while metabolic rate has to be corrected 
for partial-volume effects to be on target. Quantitative approaches that employ either 
structural or functional imaging are prone to more inaccuracy and variability than those 
utilizing both modalities.  
The extent of athereosclerosis in the aorta can also be quantified by multiplying SUV in the 
aortic wall with volumetric data of the aortic wall, as determined by CT. The resulting MVP 
value is representative of the atheroscleoritc burden in each segment of the aorta17. The same 
principles can be applied to the diffuse hepatic steatosis; hepatic MVP can be calculated by 
multiplying the mean hepatic SUV by the liver volume measured by MRI18. 
Perhaps one of the most valuable applications of global metabolic activity is in the field of 
oncology. This technique of analysis can determine the metabolic burden of individual 
lesions. Metabolic burden (MB) is calculated by multiplying the partial-volume corrected 
SUV by the volume of the lesion measured by CT and dividing the product by the recovery 
coefficient.  
 meanCT CTMB SUV V RC  
Metabolic burden is a promising method of assessing total body tumor burden, but there are 
other techniques that also draw from the concept of global metabolic activity. The measure 
of Total Lesion Glycolysis (TLG) multiplies SUV by lesion volume without accounting for 
the recovery coefficient.  
11. Image segmentation in quantitative PET imaging 
Segmentation, a crucial step in analyzing structural images, groups voxels into sets of 
distinct classes. Despite its technical complexity, the process of segmentation has breached 
the clinical field. Through segmentation, organ and tumor volume can be accurately 
measured, target treatment volumes can be defined, attenuation maps can be generated, and 
voxel-based anthropomorphic phantoms can be constructed from high resolution anatomical 
images. Approaches to segmentation are myriad, and include: 
 Thresholding 
 Region growing 
 Classifiers 
 Clustering 
 Edge detection 
 Markov random field models 
 Artificial neutral networks 
 Deformable models 
 Atlas guidance 
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The process of segmenting CT images of regions such as the lungs is normally preceded by 
inhomogeneity correction and intensity standardization, and can be accomplished through 
thresholding and the construction of masks. Subtracting masks from one another allows for 
the segmentation of smaller structures. Lesion detectability is enhanced by similarity 
measures (e.g., cross-B-energy operator), while the reliability of the algorithms behind 
partial-volume correction is dependent on the accuracy of segmentation and coregistration. 
Errors in segmentation only affect the partial-volume correction of the mis-segmented 
region19. It is believed that errors in segmentation carry greater weight in measuring the true 
tracer concentration of a region in comparison to errors in coregistration. 
12. Novel approaches to segmentation 
Image segmentation is necessary for the quantification of tumor activity, assessment of 
tumor response to treatment, and definition of target volumes for treatment20,21. 
Demarcating target regions in noisy functional images is one of the most challenging aspects 
of the oncological applications of PET. Delineating target volumes is normally operator-
dependent in the clinical setting. Since this methodology opens the door to high inter-reader 
variability, moving towards automated techniques would reduce subjectivity.  
A method for automated segmentation involving Expectation Maximization-based mixture 
modeling using k-means clustering has been proposed. A multiscale Markov model can 
refine segmentation by modeling spatial correlations between neighboring image voxels22. 
Anthropomorphic phantom experiments evaluated the proposed segmentation algorithm. 
Segmentation using the Markov Random Field Model was shown to reduce relative error. 
13. Conclusions 
The incorporation of functional imaging such as MR and CT into PET analysis has expended 
and strengthened its applications in the medical field. Measures of global metabolic activity 
that can be made with PET/CT and PET/MRI may be superior to those of SUVmax, 
especially in oncology. Further refinements might prove invaluable for the optimal 
utilization of this powerful imaging technology. 
14. View to the future  
We believe that the future of imaging is going to shift rapidly from a single modality 
approach to hybrid imaging with heavy emphasis on PET-CT and possibly PET-MRI. 
Clearly, the impact of PET-CT has been substantial in many domains. In particular, this 
approach has revolutionized the practice of oncology and other disciplines with regard to 
monitoring the effects of various interventions. In particular, PET-CT has been critical in the 
preoperative assessment of the staging of disease and optimal characterization of the 
structural abnormalities noted before surgery. Similarly, the field of radiation oncology has 
rapidly adopted PET-CT imaging for effective control of a variety of cancers, in particular, 
those that originate in the lungs and the head/neck regions. The role of contrast enhanced 
CT can be expected to decline if PET data indicates that this extra step may be redundant 
and will not substantially alter the results generated from PET alone. The role of PET-MRI is 
unclear at this time. However, its applications in the brain will obviate the need for PET-CT 
for this anatomic site. This is mainly due to the fact that information provided by CT for 
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central nervous disorders is suboptimal and therefore combined PET-MRI will provide 
superior data in the brain. It is possible that orthopedic applications of PET may 
substantially improve by combining PET and MRI, particularly in the structures of the feet 
and the knees. It is unclear whether PET-MRI will be as successful in assessing disease 
activity in the chest and abdomen. This is primarily due to the fact that attenuation 
correction in these anatomic sites is complex and may not be feasible with MR approaches 
alone. Efforts are on the way to estimate the degree of attenuation at these sites but we are 
uncertain that this will lead to overcoming the difficulties that exist in this particular 
domain. Finally, the use of hybrid imaging has substantially improved our ability to 
optimally quantify PET data. This will further enhance the role of functional imaging for 
accurate characterization of lesions and response to therapy.  
15. Summary 
The information provided in this chapter reveals a paradigm shift in medical imaging and 
has described in detail the need for hybrid imaging with an emphasis on PET-CT as major 
modality for the future in medicine. Therefore, practitioners of medicine must make every 
effort to amiliarize themselves with the capabilities of these modalities in order to optimize 
treatments and care for their patients.  
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